{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anoctamin 1", "Asthma", "CaCCs", "Cancer", "Diarrhea.", "Heart disease", "Hypertension", "Pain"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34109910", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "15"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1568026621666210607125614"], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"Volume": "21", "Issue": "13", "PubDate": {"Year": "2021"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "Advances in Anoctamin 1: A Potential New Drug Target in Medicinal Chemistry.", "Pagination": {"StartPage": "1139", "EndPage": "1155", "MedlinePgn": "1139-1155"}, "Abstract": {"AbstractText": ["ANO1, anoctamin 1(also known as TMEM16A), is the molecular basis of calcium-activated chloride channels with ten transmembrane segments which are widely expressed in mammalian cells, including epithelial cells, vascular smooth muscle tissues, electro-excitatory cells, and some tumor cells. To date, multiple studies have shown that many natural and synthetic compounds have regulatory effects on ANO1. Therefore, ANO1 could be a potential new drug target for the treatment of cancer, pain, diarrhea, hypertension, and asthma. In this study, we review the structure of ANO1 and its involvement in cancer, pain, diarrhea, hypertension, and asthma."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Zhong", "ForeName": "Junjie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Xuan", "ForeName": "Wendi", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Tang", "ForeName": "Mengting", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Cui", "ForeName": "Shihao", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Zhou", "ForeName": "Yuhang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanning, China."}], "LastName": "Qu", "ForeName": "Xiaosheng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhongshan Hospital, Institute of Clinical Science, Shanghai Medical College, Fudan University, Shanghai, China."}], "LastName": "Cao", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China."}], "LastName": "Niu", "ForeName": "Bing", "Initials": "B"}], "GrantList": [{"GrantID": "20ZR1410400", "Agency": "Natural Science Foundation of Shanghai", "Country": ""}, {"GrantID": "81771138", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "2018E10008", "Agency": "Open Funding of Key Laboratory of Diagnosis and Treatment of Severe Hepato-pancreatic Diseases of Zhejiang Province", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anoctamin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Anoctamin-1"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Asthma"}, {"QualifierName": [], "DescriptorName": "Chemistry, Pharmaceutical"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diarrhea"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Hypertension"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Pain"}, {"QualifierName": ["chemistry"], "DescriptorName": "Pharmaceutical Preparations"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "11", "Day": "15"}, {"Year": "2021", "Month": "1", "Day": "18"}, {"Year": "2021", "Month": "1", "Day": "21"}, {"Year": "2021", "Month": "6", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "10", "Hour": "10", "Minute": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34109910", "10.2174/1568026621666210607125614", "CTMC-EPUB-116003"]}}], "PubmedBookArticle": []}